RVS — Revasum Income Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
Annual income statement for Revasum, fiscal year end - January 1st, USD millions except per share, conversion factor applied.
2018 December 31st | 2020 January 5th | 2021 January 3rd | 2022 January 2nd | 2023 January 1st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 27.3 | 20.5 | 15.4 | 13.7 | 14.7 |
Cost of Revenue | |||||
Gross Profit | 10.2 | 2.29 | 4.89 | 4.84 | 4.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 28.3 | 35.4 | 24.3 | 19 | 22.6 |
Operating Profit | -1.02 | -14.9 | -8.93 | -5.24 | -7.89 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.36 | -14.9 | -9.16 | -1.97 | -8.93 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.36 | -14.9 | -9.16 | -1.97 | -8.93 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.36 | -14.9 | -9.16 | -1.97 | -8.93 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.36 | -14.9 | -9.16 | -1.97 | -8.93 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.037 | -0.176 | -0.078 | -0.019 | -0.083 |